Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VERTICAL: Velcade + Bendamustine + Rituximab in Follicular Lymphoma
NCT00636792Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Feb 2008
- Primary completion
- May 2010
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in follicular lymphoma (FL), sponsored by Millennium Pharmaceuticals. Started Feb 2008; status: completed.
02
Drugs
bortezomib
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00636792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00636792.